On June 26, 2024, Takeda Pharmaceutical Co. held its 148th Ordinary General Meeting where shareholders approved key resolutions, including a year-end dividend of 94 yen per share and the election of 14 directors. The voting results indicated strong support, with the first proposal receiving 97.67% approval.